Lakefront Biotherapeutics N.V. (LKFT)

U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus

Lakefront Receives Transparency Notification from Bank of America

Acquisition of Own Shares

Acquisition of Own Shares

Acquisition of Own Shares

Acquisition of Own Shares

Inkoop van eigen aandelen

Acquisition of Own Shares

Acquisition of Own Shares

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

Lakefront kondigt het terugtreden van Paulo Fontoura uit de Raad van Bestuur aan na zijn benoeming tot Global Head of Research & Development bij Sanofi

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

Acquisition of Own Shares

Acquisition of Own Shares

Lakefront Receives Transparency Notification from Madison Avenue Partners

Acquisition of Own Shares

Acquisition of Own Shares

Lakefront Announces Initiation of €50 Million Stock Repurchase Program

Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer